Status:
COMPLETED
DEXINEURO® Tab on Blood Glucose Reduction in Patients With Type 2 Diabetes Accompanied by Diabetic Peripheral Neuropathy
Lead Sponsor:
Hanlim Pharm. Co., Ltd.
Conditions:
Diabetic Peripheral Neuropathy
Eligibility:
All Genders
19+ years
Brief Summary
This study is to evaluate the efficacy of DEXINEURO® tab on blood glucose reduction and assess the interaction with concomitantly administered insulin or oral antidiabetic agents in patients with type...
Detailed Description
This clinical trial is a multi-center, single-group, prospective observational study conducted to investigate the interaction with concomitant insulin or oral antidiabetic agents and assess the influe...
Eligibility Criteria
Inclusion
- Adults aged 19 years and older of both genders.
- Type 2 diabetes patients with HbA1c ≤ 10% at screening.
- Patients diagnosed with diabetic peripheral neuropathy who are scheduled to receive DEXINEURO® tab.
- Individuals who have voluntarily provided written consent to participate in this study.
Exclusion
- Individuals who have taken or are currently taking alpha-lipoic acid (thioctic acid) within 1 month before screening.
- Individuals contraindicated according to the approval conditions of DEXINEURO® tab.
- Pregnant or breastfeeding women.
- Individuals participating in other clinical trials (except for non-interventional observational studies, if they have not received investigational drugs, or are participating in other non-interventional observational studies).
- Individuals whom the principal investigator deems inappropriate for participation in this study for reasons other than those mentioned above.
Key Trial Info
Start Date :
May 19 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
528 Patients enrolled
Trial Details
Trial ID
NCT06191614
Start Date
May 19 2022
End Date
June 30 2023
Last Update
February 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Keimyung University Dongsan Hospital
Daegu, South Korea